Results Confirm and Extend Response Results from Phase 3 FLASH Study PRINCETON, N.J., May 4, 2023 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today positive… Read More..

SKYX website portfolio now spans 64 websites for lighting and home décor products - including most leading U.S. lighting brands Acquisition expected to accelerate SKYX's go-to-market for its plug and play safe and smart ceiling platform products with retail and professional segments including builders, architects and designers MIAMI FL /… Read More..

Presentation Focused on Positive Results from Recent Phase 2a Study PITTSBURGH, May 1, 2023 /PRNewswire/ -- Lipella Pharmaceuticals Inc. (Nasdaq: "LIPO") ("Lipella," "our, "us" or the "Company"), a clinical-stage biotechnology company addressing serious diseases with significant unmet need, today announced that it has delivered a late-breaking presentation at the annual… Read More..